Stressgen (VSE: SSB) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Stressgen (VSE: SSB)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andy Patton who started this subject	6/24/2002 2:39:58 AM
From: michael_f_murphy	Read Replies (1) of 236

Stressgen announces June 24, 2002 conference call to discuss Roche collaboration Conference Call Scheduled for 9:00 am EST VICTORIA, BC, Canada and SAN DIEGO, CA, USA, June 24 /PRNewswire- FirstCall/ - Stressgen Biotechnologies Corporation (TSX:SSB - News) announced today that it will hold a conference call on Monday, June 24, 2002 at 9:00 a.m. Eastern Standard Time (6:00 a.m. Pacific Standard Time) to discuss today's announcement of a Collaboration Agreement with Roche for Stressgen's lead product, HspE7. To participate in the conference call: Dial: 1 800 915-4836 (U.S. and Canada) 1 973 317-5319 (international) No passcode necessary Post-view for conference call: Dial: 1 800 428-6051 (U.S. and Canada) 1 973 709-2089 (international) Passcode: 248609 Available June 24 - July 1, 2002

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next